» Articles » PMID: 35565943

Intestinal Microbiota-Derived Short Chain Fatty Acids in Host Health and Disease

Overview
Journal Nutrients
Date 2022 May 14
PMID 35565943
Authors
Affiliations
Soon will be listed here.
Abstract

Intestinal microbiota has its role as an important component of human physiology. It produces metabolites that module key functions to establish a symbiotic crosstalk with their host. Among them, short chain fatty acids (SCFAs), produced by intestinal bacteria during the fermentation of partially and non-digestible polysaccharides, play key roles in regulating colon physiology and changing intestinal environment. Recent research has found that SCFAs not only influence the signal transduction pathway in the gut, but they also reach tissues and organs outside of the gut, through their circulation in the blood. Growing evidence highlights the importance of SCFAs level in influencing health maintenance and disease development. SCFAs are probably involved in the management of host health in a complicated (positive or negative) way. Here, we review the current understanding of SCFAs effects on host physiology and discuss the potential prevention and therapeutics of SCFAs in a variety of disorders. It provides a systematic theoretical basis for the study of mechanisms and precise intake level of SCFAs to promote human health.

Citing Articles

Bioactive lipid signaling and lipidomics in macrophage polarization: Impact on inflammation and immune regulation.

Rodriguez J, Casas J, Balboa M, Balsinde J Front Immunol. 2025; 16:1550500.

PMID: 40028333 PMC: 11867965. DOI: 10.3389/fimmu.2025.1550500.


Gut Microbiome, Diet and Depression: Literature Review of Microbiological, Nutritional and Neuroscientific Aspects.

Clerici L, Bottari D, Bottari B Curr Nutr Rep. 2025; 14(1):30.

PMID: 39928205 PMC: 11811453. DOI: 10.1007/s13668-025-00619-2.


Predicting metabolite response to dietary intervention using deep learning.

Wang T, Holscher H, Maslov S, Hu F, Weiss S, Liu Y Nat Commun. 2025; 16(1):815.

PMID: 39827177 PMC: 11742956. DOI: 10.1038/s41467-025-56165-6.


Short-chain fatty acids as a novel intervention for high-fat diet-induced metabolic syndrome.

Sharma T, Ranawat P, Garg A, Rastogi P, Kaushal N Mol Cell Biochem. 2024; .

PMID: 39709317 DOI: 10.1007/s11010-024-05185-9.


Intestinal Insights: The Gut Microbiome's Role in Atherosclerotic Disease: A Narrative Review.

Alexandrescu L, Suceveanu A, Stanigut A, Tofolean D, Axelerad A, Iordache I Microorganisms. 2024; 12(11).

PMID: 39597729 PMC: 11596410. DOI: 10.3390/microorganisms12112341.


References
1.
Wilck N, Matus M, Kearney S, Olesen S, Forslund K, Bartolomaeus H . Salt-responsive gut commensal modulates T17 axis and disease. Nature. 2017; 551(7682):585-589. PMC: 6070150. DOI: 10.1038/nature24628. View

2.
Reshef L, Niv J, Shapiro B . Effect of propionate on lipogenesis in adipose tissue. J Lipid Res. 1967; 8(6):682-7. View

3.
Waalen J . The genetics of human obesity. Transl Res. 2014; 164(4):293-301. DOI: 10.1016/j.trsl.2014.05.010. View

4.
Hippe B, Zwielehner J, Liszt K, Lassl C, Unger F, Haslberger A . Quantification of butyryl CoA:acetate CoA-transferase genes reveals different butyrate production capacity in individuals according to diet and age. FEMS Microbiol Lett. 2011; 316(2):130-5. DOI: 10.1111/j.1574-6968.2010.02197.x. View

5.
Topping D, Clifton P . Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev. 2001; 81(3):1031-64. DOI: 10.1152/physrev.2001.81.3.1031. View